Advertisement

Clinical Pharmacokinetics

, Volume 26, Issue 5, pp 356–373 | Cite as

Drugs in Semen

  • Simona Pichini
  • Piergiorgio Zuccaro
  • Roberta Pacifici
Review Article Drug Disposition

Summary

Over the past 50 years, a decline in the quality of semen has been observed, possibly resulting in a reduction in male fertility. Among the factors affecting semen quality, exposure to drugs is of particular importance. It is known that drugs can be transported to the seminal plasma, which is made up of secretions from the various accessory genital glands. There is evidence that many drugs enter the male genitourinary tract by an ion-trapping process. Lipid solubility and the degree of ionisation of the drug, which depend on the pH of plasma and seminal fluid, are important factors in this process.

To date, few studies have been conducted on this topic. Pharmacokinetic evaluation of the fluids of the male accessory gland have been performed in the case of chloroquine and caffeine only, while the effects of mesalazine (5-aminosalicylic acid), sulfasalazine, salicylate, propranolol, diltiazem, flunarizine, verapamil, caffeine and nicotine on sperm physiology and morphology have been examined. Although data from the literature are scarce and incomplete, it is evident that many drugs can be excreted into semen. These drugs may interfere with the most common semen characteristics, potentially resulting in a male-mediated teratogenic effect, or local and systemic responses in female recipients.

Therefore, it may be advisable to include, in the processes of drug development, pharmacokinetic evaluation of a drug in the semen and analysis of standard microscopic parameters of the semen. This is particularly important for drugs known to concentrate in the semen.

Keywords

Naltrexone Sperm Motility Prostatitis Mesalazine Seminal Plasma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams PC, Holt P, Holt DW. Amiodarone in testis and semen. Lancet 1: 341, 1985PubMedCrossRefGoogle Scholar
  2. Aeschbacher HU, Milon H, Wurzner HP. Caffeine concentration in mice plasma and testicular tissue and the effect of caffeine on the dominant lethal test. Mutation Research 57: 193–200, 1978PubMedCrossRefGoogle Scholar
  3. Ammatuna P, Romano C, Falletta C, Tripi M, Di Trapani D, et al. Concentrazioni di aztreonam nel plasma, nell’urina e nel liquido seminale di soggetti affetti da prostatite cronica. Archivio Italiano di Urologia 64: 177–181, 1992Google Scholar
  4. Armstrong JR, Cook FE, Robinson JR. Concentration of antibiotic and chemotherapeutic agents in the ejaculum. Journal of Urology 100: 72–76, 1968PubMedGoogle Scholar
  5. Atkinson RL. Evaluation of antibiotics in treatment for chronic prostatitis. Geriatrics 12: 515–520, 1957PubMedGoogle Scholar
  6. Beach CA, Bianchine JR, Gerber N. The excretion of caffeine in the semen of men: pharmacokinetics and comparison of the concentrations in blood and semen. Journal of Clinical Pharmacology 24: 120–126, 1984PubMedGoogle Scholar
  7. Berger SA, Yavetz H, Paz G, Gorea A, Homonnai Z. Concentration of ofloxacin and ciprofloxacin in human semen following a single oral dose. Journal of Urology 144: 683–684, 1990PubMedGoogle Scholar
  8. Bimie GG, McLeod TIF, Watkinson G. Incidence of sulphasalazine-induced male infertility. Gut 22: 452–455, 1981CrossRefGoogle Scholar
  9. Boerema JBJ, Dalhoff A, Debruyne FMA. Ciprofloxacin distribution in prostatic tissue and fluid following administration. Chemotherapy 31: 13–18, 1985PubMedCrossRefGoogle Scholar
  10. Bologna M, Vaggi L, Flammini D, Carlucci G, Francavilla F. Norfloxacin concentrations in seminal plasma measured by HPLC. Drugs Experimental and Clinical Research 11: 801–804, 1985Google Scholar
  11. Borski AA, Pulaski EJ, Kimbrough JC, Fusillo MH. Prostatic fluid, semen and prostatic tissue concentrations of the major antibiotics following intravenous administration. Antibiotics and Chemotherapy 4: 905–910, 1954Google Scholar
  12. Brady K, Herrera Y, Zenick H. Influence of parental lead exposure on subsequent learning ability of offspring. Pharmacology, Biochemistry and Behaviour 3: 561–565, 1975CrossRefGoogle Scholar
  13. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during past 50 years. British Medical Journal 305: 609–613, 1992PubMedCrossRefGoogle Scholar
  14. Cicero TJ, Meyer ER, Bell RD, Wiest WG. Effects of morphine on the secondary sex organs and plasma testosterone levels of rats. Research Communications in Chemical Pathology and Pharmacology 7: 17–24, 1974PubMedGoogle Scholar
  15. Cicero TJ, Meyer ER, Wiest WG, Olney JW, Bell RD. Effects of chronic morphine administration on the reproductive system of the male rat. Journal of Pharmacology and Experimental Therapeutics 192: 542–548, 1975PubMedGoogle Scholar
  16. Comhaire FH. Concentration of pefloxacine in split ejaculates of patients with chronic male accessory gland infection. Journal of Urology 138: 828–830, 1987PubMedGoogle Scholar
  17. Dalet F, Marina S, Gimeno E, Pomerol J. Cephalexin concentration in the human ejaculate following oral and parenteral administration. Andrologia 10: 142–148, 1978PubMedCrossRefGoogle Scholar
  18. Dalhoff A, Weidner W. Diffusion of ciprofloxacin into prostatic fluid. European Journal of Clinical Microbiology 4: 360–362, 1984CrossRefGoogle Scholar
  19. De Benedetti H, Ventura M. Cloroamfenicolo e liquido seminale. Minerva Urologica 6: 148–150, 1954Google Scholar
  20. Eliasson R, Dornbusch K. Levels of trimethoprim and sulphamethoxazole in human seminal plasma. Andrologia 9: 195–202, 1977PubMedCrossRefGoogle Scholar
  21. Eliasson R, Dornbusch K. Secretion of metronidazole into the human semen. International Journal of Andrology 3: 236–242, 1980PubMedCrossRefGoogle Scholar
  22. Ericsson RJ, Baker VF. Transport of oestrogens in semen to the female rat during mating and its effect on fertility. Journal of Reproduction and Fertility 12: 381–384, 1966PubMedCrossRefGoogle Scholar
  23. Ette EI, Ogonor JI, Essien EE. Passage of chloroquine into semen. British Journal of Clinical Pharmacology 26: 179–182, 1988PubMedCrossRefGoogle Scholar
  24. Evans HJ, Fletcher J, Torrance M, Hargreave TB. Sperm abnormalities and cigarette smoking. Lancet 1: 627–629, 1981PubMedCrossRefGoogle Scholar
  25. Fredricsson B, Gilljam H. Smoking and reproduction: short and long term effects and benefits of smoking cessation. Acta Obstetricia et Gynecologica Scandinavica 71: 580–592, 1992PubMedCrossRefGoogle Scholar
  26. Friedler G. Effects of limited maternal exposure to xenobiotic agents on the development of progeny. Neurobehavioral Toxicology and Teratology 7: 739–743, 1985PubMedGoogle Scholar
  27. Friedman L, Weinberger MA, Farber TM, Moreland FM, Peters EL, et al. Testicular atrophy and impaired spermatogenesis in rats fed high levels of the methylxanthines caffeine, theobromine or theophylline. Journal of the Environmental Pathology and Toxicology 2: 687–706, 1979Google Scholar
  28. Gagnon C (Ed). Controls of sperm motility: biological and clinical aspects. CRC Press, Boca Raton, Florida, 1990Google Scholar
  29. Gerber N, Lynn RK. Excretion of methadone in semen from methadone addicts; comparison with blood levels. Life Sciences 19: 787–792, 1976PubMedCrossRefGoogle Scholar
  30. Gnarpe H, Friberg J. Mycoplasma and human reproductive failure. American Journal of Obstetrics and Gynecology 114: 963–966, 1972PubMedGoogle Scholar
  31. Grabe M, Hellstem S, Forsgren A. The effects of a short and a prolonged perioperative course of ciprofloxacin in TUR compared with a control group without antibiotics. Abstract 179. Proceedings of the International Symposium on New Quinolones, Geneva, July 17–19, 1986Google Scholar
  32. Hales BF, Smith S, Robaire B. Cyclophosphamide in the seminal fluid of treated males: transmission to females by mating and effect on pregnancy outcome. Toxicology and Applied Pharmacology 84: 423–430, 1986PubMedCrossRefGoogle Scholar
  33. Hall AR. The treatment of malaria. British Medical Journal 1: 323–328, 1976PubMedCrossRefGoogle Scholar
  34. Harrison RF, Sheppard BL, Kaliszer M. Observations on motility, ultrastmcture and elemental composition of human spermatozoa incubated with caffeine: II. a time consequence study. Andrologia 12: 434–443, 1980PubMedCrossRefGoogle Scholar
  35. Hong CY, Chaput De Saintonge DM, Turner P. The inhibitory action of procaine, (+)-propranolol and (±)-propranolol on human sperm motility: antagonism by caffeine. British Journal of Clinical Pharmacology 12: 751–753, 1981PubMedCrossRefGoogle Scholar
  36. Hong CY, Chiang BN, Ku J, Wei YH, Fong JC. Calcium antagonists stimulate sperm motility in ejaculated human semen. British Journal of Clinical Pharmacology 19: 45–49, 1985PubMedCrossRefGoogle Scholar
  37. Kaufman SN, Lynn RK, Gerber N. Excretion of primidone and its active metabolites in the semen of rabbit and man. Federation Proceedings 39: 4382, 1980Google Scholar
  38. Kershaw RA, Mays DC, Bianchine JR, Gerber N. Disposition of aspirin and its metabolites in the semen of man. Journal of Clinical Pharmacology 27: 304–309, 1987PubMedGoogle Scholar
  39. Kjaergaard N, Ambrosius Christensen L, Lauritsen JG, Norby Rasmussen S, Honorè Hansen S. Effects of mesalazine substitution on salicylazosulfapyridine-induced seminal abnormalities in men with ulcerative colitis. Scandinavian Journal of Gastroenterology 24: 891–896, 1989PubMedCrossRefGoogle Scholar
  40. Lewis R, Lauresen NJ, Birnbaum S. Malaria associated with pregnancy. Obstetrics and Gynecology 42: 698–700, 1978Google Scholar
  41. Lundquist F. Aspects of the biochemistry of human semen. Acta Physiologica Scandinavica 19 (Suppl. 66): 1–95, 1949Google Scholar
  42. Lutwak-Mann C, Schmid K, Keberle H. Observation of the progeny of treated male rabbits. British Medical Journal 1: 1090–1091, 1964PubMedCrossRefGoogle Scholar
  43. Lutwak-Mann C, Schmid K, Keberle H. Thalidomide in rabbit semen. Nature 214: 1018–1020, 1967PubMedCrossRefGoogle Scholar
  44. Madsen PO, Wolf H, Barquin OP, Rhodes P. The nitrofurantoin concentration in prostatic fluid of humans and dogs. Journal of Urology 100: 54–56, 1968PubMedGoogle Scholar
  45. Mahajan P, Grech ED, Pearson RM, Ridgway EJ, Tumer R. Propranolol concentrations in blood serum, seminal plasma and saliva in man after a single oral dose. British Journal of Clinical Pharmacology 18: 849–852, 1984PubMedCrossRefGoogle Scholar
  46. Malmborg AS. Antimicrobial drugs in human seminal plasma. Journal of Antimicrobial Chemotherapy 4: 483–485, 1978PubMedCrossRefGoogle Scholar
  47. Milingos S, Creatsas G, Kallipolitis G, Lolis D, Pavlatos M, et al. An appraisal of cephalexin and clindamycin concentration in seminal plasma. Acta Europaea Fertilitatis 12: 319–321, 1981PubMedGoogle Scholar
  48. Naber KG, Kinzig M, Adam D, Sorgel F, Bajorski AH, et al. Concentrations of cefpodoxime in plasma, ejaculate and in prostatic fluid and adenoma tissue. Infection 19: 30–35, 1991PubMedCrossRefGoogle Scholar
  49. Naber KG, Sorgel F, Kees F, Jaehde U, Schumacher H. Brief Report: Pharmacokinetics of ciprofloxacin in young (healthy volunteers) and elderly patients, and concentrations in prostatic fluid, seminal fluid, and prostatic adenoma tissue following intravenous administration. American Journal of Medicine 87 (Suppl. 5A): 57–59, 1989bCrossRefGoogle Scholar
  50. Naber KG, Sorgel F, Kees F, Schumacher H, Metz R, et al. In-vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and prostatic fluid and in prostatic adenoma tissue. Journal of Antimicrobial Chemotherapy 22 (Suppl. D): 199–207, 1988PubMedGoogle Scholar
  51. Naber KG, Sorgel F, Kees F, Schumacher H, Sigl G, et al. Enoxacin-konzentrationen in der samenflussigkeit, im prostatasekret und im prostataadenomgewebe nach oraler gabe oder intravenoser infusion. Infection 17: 30–36, 1989aCrossRefGoogle Scholar
  52. Pacifici R, Altieri I, Gandini L, Lenzi A, Pichini S, et al. Nicotine, cotinine and trans-3-hydroxycotinine levels in seminal plasma of smokers: effects on sperm parameters. Therapeutic Drug Monitoring 15: 358–363, 1993PubMedCrossRefGoogle Scholar
  53. Pak K, Kim CJ, Ishida A, Kushima M, Tomoyoshi T, et al. Cyclosporin levels in semen of renal transplant patients. Nippon Hinyokika Gakkai Zasshi 81(10): 1494–1499, 1990PubMedGoogle Scholar
  54. Paladine WJ, Cunningham TJ, Donavan MA, Dumper CW. Possible sensitivity to vinblastine in prostatic or seminal fluid. New England Journal of Medicine 292: 52, 1975PubMedGoogle Scholar
  55. Plomp TA, Mattelaer JJ, Maes RAA. The concentration of thiamphenicol in seminal fluid and prostatic tissue. Journal of Antimicrobial Chemotherapy 4: 65–71, 1978PubMedCrossRefGoogle Scholar
  56. Porat-Soldin O, Soldin SJ. Preliminary studies on the in vitro and in vivo effect of salicylate on sperm motility. Therapeutic Drug Monitoring 14: 366–370, 1992PubMedCrossRefGoogle Scholar
  57. Pulaski EJ, Sprinz H. Streptomycin in surgical infections: laboratory studies. Annals of Surgery 125: 194–202, 1947CrossRefGoogle Scholar
  58. Riccardi R, Vigersky RA, Barnes S, Archie Bleyer W, Poplack DG. Methotrexate levels in the interstitial space and seminiferous tubule of rat testis. Cancer Research 42: 1617–1619, 1982PubMedGoogle Scholar
  59. Riley SA, Lecarpentier J, Mani V, Goodman MJ, Mandai BK, et al. Sulphasalazine induced semen abnormalities in ulcerative colitis: results of mesalazine substitution. Gut 28: 1008–1012, 1987PubMedCrossRefGoogle Scholar
  60. Rimerman RA, Taylor SM, Lynn RK, Rodger RM, Gerber N. The excretion of carbamazepine in the semen of the rabbit and man: comparison of the concentration in semen and plasma. Pharmacologist 21: 264, 1979Google Scholar
  61. Rubi R, Galan HM. Cephapirin concentrations in prostatic and seminal vesicle tissues. International Journal of Clinical Pharmacology and Biopharmacy 17: 87–89, 1979PubMedGoogle Scholar
  62. Schatten WE, Persky L. Aureomycin therapy of chronic prostatitis. Surgery, Gynecology and Obstetrics 98: 40–44, 1954PubMedGoogle Scholar
  63. Schramm P. Ofloxacin: concentration in human ejaculate and influence on sperm motility. Infection 14 (Suppl. 4): 274–275, 1986CrossRefGoogle Scholar
  64. Schramm P, Schopf RE, Wildfeuer A. Josamycin concentration in human ejaculate and its influence on sperm motility-A contribution to antibiotic therapy in andrological patients. Andrologia 20: 521–525, 1988PubMedCrossRefGoogle Scholar
  65. Smith FP. Detection of amphetamine in bloodstains, semen, seminal stains, saliva, and saliva stains. Forensic Science 17: 225–228, 1981CrossRefGoogle Scholar
  66. Swanson BN, Gordon WP, Lynn RK, Gerber N. Seminal excretion, vaginal absorption, distribution and whole blood kinetics of dmethadone in the rabbit. Journal of Pharmacology and Experimental Therapeutics 206: 507–514, 1978aPubMedGoogle Scholar
  67. Swanson BN, Harland RC, Dickinson RG, Gerber N. Excretion of valproic acid into semen of rabbits and man. Epilepsia 19: 541–546, 1978bPubMedCrossRefGoogle Scholar
  68. Swanson BN, Leger RM, Gordon WP, Lynn RK, Gerber N. Excretion of Phenytoin into semen of rabbits and man: comparison with plasma levels. Drug Metabolism and Disposition 6: 70–74, 1978cPubMedGoogle Scholar
  69. Taylor SM, Rodgers RM, Lynn RK, Gerber N. The seminal excretion, plasma elimination, tissue distribution and metabolism of naltrexone in the rabbit. Journal of Pharmacology and Experimental Therapeutics 213: 289–299, 1980PubMedGoogle Scholar
  70. Toth A. Reversible toxic effect of salicylazo-sulphapyridine on semen quality. Fertility and Sterility 31: 538–540, 1979PubMedGoogle Scholar
  71. Ward MJ, Routledge PA, Hutchings A, Morris JM. Association of seminal desethylamiodarone concentration and epididymitis with amiodarone treatment. British Medical Journal 296: 19–20, 1988PubMedCrossRefGoogle Scholar
  72. Whorton D, Krauss RM, Marshall S, Milby TH. Infertility in male pesticide workers. Lancet 2: 1259–1261, 1977PubMedCrossRefGoogle Scholar
  73. Wildfeuer A, Lemme JD. Zür Pharmakokinetik von Josamycin. Drug Research 35: 639–643, 1985PubMedGoogle Scholar
  74. Winningham DG, Nemoy NJ, Stamey TA. Diffusion of antibiotics from plasma into prostatic fluid. Nature 219: 139–143, 1968PubMedCrossRefGoogle Scholar
  75. Winningham DG, Stamey TA. Diffusion of sulfonamides from plasma into prostatic fluid. Journal of Urology 104: 559–563, 1970PubMedGoogle Scholar
  76. Wong PYD, Lau SKD, Fu WO. Antifertility effects of some sulphonamides and related compounds and their accumulation in the epididymides of male rats. Journal of Reproduction and Fertility 81: 259–267, 1987PubMedCrossRefGoogle Scholar
  77. Yasumoto R, Asakawa M. Enoxacin in the seminal fluid of prostatitis patients. Hinyokika Kiyo 34: 1101–1103, 1988PubMedGoogle Scholar
  78. Yazigi RA, Polakoski KL. Distribution of tritiated cocaine in selected genital and nongenital organs following administration to male mice. Archives of Pathology and Laboratory Medicine 116: 1036–1039, 1992PubMedGoogle Scholar
  79. Zipper J, Wheeler RG, Potts DM, Rivera M. Propranolol as a novel, effective spermicide: preliminary findings. British Medical Journal 287: 1245–1246, 1983PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1994

Authors and Affiliations

  • Simona Pichini
    • 1
  • Piergiorgio Zuccaro
    • 1
  • Roberta Pacifici
    • 1
  1. 1.Clinical Biochemistry UnitIstituto Superiore di SanitàRomeItaly

Personalised recommendations